ijms-logo

Journal Browser

Journal Browser

Gene Therapy Approaches in Haploinsufficiency Disorders

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 33

Special Issue Editor


E-Mail Website
Guest Editor
Medical Genetics Unit, S. Maria della Misericordia Hospital, University of Perugia, 06123 Perugia, Italy
Interests: clinical genetics; medical genetics; cytogenomics; next-generation sequencing technologies applied to human genetics; epigenetics; genotype–phenotype correlation studies in genetic diseases; genetics of intellectual disability and autism; genetics of epilepsy; genetics prenatal diagnosis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Haploinsufficiency disorders (HDs) are a class of genetic diseases associated mainly with intellectual disability, developmental anomalies, metabolic dysfunctions, or tumorigenesis. The pathogenic mechanism involves the insufficient expression of one or more genes, resulting in transcript levels reduced to approximately half of normal. Human genetic variation does not only comprise single nucleotide variants (SNVs) or allelic variation at a single genetic locus. The inherent structure of the human genome, characterized by the presence of low copy repeats (LCRs), predisposes to non-allelic homologous recombination (NAHR) between flanking regions, leading to genomic rearrangements such as deletions and duplications. Although less frequently reported, non-homologous end joining (NHEJ) can also contribute to structural alterations. Despite mechanistic differences, these genomic and transcriptional alterations converge on a common outcome: the disruption of gene dosage balance, with downstream effects on essential cellular and molecular pathways. This Special Issue will focus on avenue gene therapy strategies aimed at restoring functional mRNA and protein levels to rescue the phenotype, with particular attention to molecular innovations such as gene augmentation, RNA therapeutic oligonucleotides (e.g., SINEUPs, ASOs), CRISPR-based transcriptional activation, epigenetic modulation, and even complementary pharmacological strategies modulating disrupted signaling pathways. 

Dr. Paolo Prontera
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • haploinsufficiency disorders
  • molecular medicine
  • gene dosage imbalance
  • RNA-based therapy
  • CRISPR activation
  • transcriptomic regulation
  • epigenetic modulation
  • gene therapy
  • neurodevelopment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop